Amendment vs bill Senate Committee Amendment, #4437, INS, Draft vs Enrolled

Struck = removed from the bill · added = the amendment's new text.

Previous
Latest
ENROLLED Regular Session HOUSE BILL NO.
SCAHB761 3275 4437 SENATE COMMITTEE AMENDMENTS Regular Session Amendments proposed bySenate Committee on Insurance to Reengrossed House Bill No.
761 BY REPRESENTATIVES HILFERTY, ADAMS, BAYHAM, BILLINGS, WILFORD CARTER, CHASSION, FISHER, GREEN, LACOMBE, LAFLEUR, TERRY LANDRY, LARVADAIN, MARCELLE, MARTINEZ, PHELPS, SPELL, TAYLOR, WALTERS, AND ZERINGUE AN ACT To amend and reenact R.S.
by Representative Hilferty AMENDMENT NO.
22:1076.1, relative to the advisory board for rare cancer treatments;
1 On page 2, at the beginning of line 2, change "The" to "the" AMENDMENT NO.
to provide for revisions to board composition;
2 On page 2, line 16, after "chairperson." change "Within" to "Within" AMENDMENT NO.
to provide for meetings and reporting;
3 On page 2, at the beginning of line 17, change "forty-five days of" to "No later than forty- five days of after" Page 1 of 1
to provide for effectiveness;
and to provide for related matters.
Be it enacted by the Legislature of Louisiana:
Section 1.
R.S.
22:1076.1 is hereby amended and reenacted to read as follows:
§1076.1.
Advisory board;
composition;
recommendations for treatment of rare cancers;
meetings;
rulemaking A.Thereisherebycreatedwithinthedepartmentanadvisoryboardthatshall review and provide medical recommendations to approve new treatments for rare cancers.The advisory board shall be composed of the following seventeen members:
(1) The commissioner or his designee.
(2) The secretaryor designee of the Louisiana Department of Health.
(3) The Medicaid Director or designee of the Louisiana Department of Health.
(4) The surgeon general or his designee.
(5) TheexecutivedirectorordesigneeofTakingAimatCancerinLouisiana the Cancer Association of Louisiana.
(6) ThechiefexecutiveofficeroftheLouisianaAssociationofHealthPlans.
(7) The chief medical officer or designee of a managed care organization.
(8) The director or designee of the Louisiana Tumor Registry.
(9) ThedirectorordesigneeofthePenningtonBiomedicalResearchCenter.
(10) A designee of the Louisiana Cancer Research Center.
Page 1 of 2 CODING:
Wordsinstruckthroughtypearedeletionsfromexistinglaw;wordsunderscored are additions.
HB NO.
761 ENROLLED (11) A designee of the LSU Health Sciences Center at New Orleans, specializing in oncology.
(12) A designee of the Tulane Medical School, specializing in oncology.
(13) A designee of the Xavier Ochsner College of Medicine.
(14) Two Four oncologists specializing in the treatments of rare cancers.
B.(1) The chairperson of the advisoryboard shall be the executive director or designee of the Louisiana Cancer Research Center.
(2) Theadvisoryboardshallholdquarterlypublicmeetingsunlessotherwise provided byvote of the advisoryboard or byorder of the chairperson.
Within thirty No later than forty-five days of after eachmeeting, the advisoryboard shall compile a report of its findings and submit a formal written report to the legislature House Committee on Insurance and the Senate Committee on Insurance.
C.
The commissioner may promulgate and adopt administrative rules and regulations in accordancewith theAdministrative ProcedureActasarenecessaryto implement the provisions of this Section.
Section 2.
Show all 45 changed rows (5 more)
Previous
Latest
This Act shall become effective upon signature bythe governor or, if not signedbythegovernor,uponexpirationofthetimeforbillstobecomelawwithoutsignature by the governor, as provided by Article III, Section 18 of the Constitution of Louisiana.
If vetoed bythe governorand subsequentlyapprovedbythe legislature, this Act shall become effective on the dayfollowing such approval.
SPEAKER OF THE HOUSE OF REPRESENTATIVES PRESIDENT OF THE SENATE GOVERNOR OF THE STATE OF LOUISIANA APPROVED:
Page 2 of 2 CODING:
Wordsinstruckthroughtypearedeletionsfromexistinglaw;wordsunderscored are additions.